evo301
·Code: EVO301
evo301: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Evommune, Inc. (EVMN) | Phase 2 |
Clinical Trials (1)
A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study of EVO301 in Adults With Atopic Dermatitis
Frequently asked questions
Who is developing evo301?
evo301 is being developed by Evommune, Inc..
How many clinical trials involve evo301?
BioSniper tracks 1 clinical trial involving evo301.
Get deeper analysis on evo301
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis